Clinical Researcher—February 2019 (Volume 33, Issue 2) EXECUTIVE DIRECTOR’S MESSAGE Jim Kremidas Clinical research is a valuable profession, and it deserves to be treated as such. Whether […]
Clinical Researcher—February 2019 (Volume 33, Issue 2) CHAIR’S MESSAGE John P. Neal, CRCP We’ve had a strong start out of the gate for 2019, and the year ahead […]
Clinical Researcher—February 2019 (Volume 33, Issue 2) SCIENCE & SOCIETY Daniel Kavanagh, PhD This article will provide a brief overview of the state of genome-editing technologies as […]
A spate of late 2018 U.S. Food and Drug Administration guidances on gene therapy has significantly changed the 2019 clinical trial landscape, warns Meagan Vaughn, PhD, RAC, a research scientist […]
Tracking key operational indicators such as site activation, enrollment, and monitoring targets can help identify problems in clinical trial projects while they are still relatively tiny and manageable, says Cynthia […]